Fluciclovine PET/CT in Multiple Myeloma Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOslo University Hospital
About this trial
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
Eligibility criteria
Qualifiers
Multiple myeloma patients suitable for ASCT treatment
Disqualifiers
Patients with contraindications to ASCT treatment
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov